Lipopolysaccharide-Enhanced Early Proliferation of Insulin Secreting Nit-1 Cell is Associated with Nuclear Factor-Kappab-Mediated Inhibition of Caspase 3 Cleavage

Liu Shan-ying,Liang Qi-jun,Lin Tian-xin,Fan Xin-lan,Liang Ying,Uwe Heemann,Li Yan
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.2011.22.010
IF: 6.133
2011-01-01
Chinese Medical Journal
Abstract:BACKGROUND:Increased levels of plasma lipopolysaccharide (LPS) have been found in obesity and diabetes patients. This study was to investigate the effect of LPS on pancreatic beta-cell viability and the involvement of caspase 3 in NIT-1 cell line.METHODS:Mouse insulinoma NIT-1 cells were treated with LPS for the indicated time and dose. Cell viability was measured by cell counting kit-8 reagent. Toll-like receptor 4 (TLR4), caspase 3 and cleaved caspase 3 were detected by Western blotting. Insulin was determined by radioimmunoassay (RIA).RESULTS:LPS promoted NIT-1 cell proliferation at 1 µg/ml, peaked at 72 hours of incubation. A reduction in cleavage of caspase 3 was observed upon LPS treatment. Bay11-7082, a specific inhibitor of nuclear factor (NF)-κB, blunted LPS-induced inhibition of caspase 3 cleavage. Reduction in chronic insulin secretion was observed after treatment with LPS at 1 µg/ml for 48 and 72 hours, not for 24 hours. TLR4 protein was upregulated when NIT-1 cells were treated with LPS at 1 µg/ml for 24 hours.CONCLUSIONS:LPS promotes early NIT-1 cell proliferation in association with NF-κB-mediated inhibition of caspase 3 cleavage. LPS exerts a time-dependent inhibitory effect on chronic insulin secretion from NIT-1 cells.
What problem does this paper attempt to address?